vanoxerine
Sign in to saveAlso known as GBR 12909, GBR12909, 1-{2-[bis(p-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine
Vanoxerine is an investigational drug which is being evaluated for the treatment of heart arrhythmias and cocaine dependence. Vanoxerine is a piperazine derivative which has multiple pharmacological activities including acting as an dopamine reuptake inhibitor, serotonin transporter inhibitor, and as a blocker of the cardiac hERG repolarizing potassium channel (IKr).
Research
530 papersvia PubMed
~7 min read
Encyclopedic overview
12 sectionsContents
- Research
- Treatment of cocaine dependence
- Antiarrhythmic
- Miscellaneous
- Pharmacology
- Mechanism of action
- Society and culture
- History
- Chemistry
- Synthesis
- See also
- References
Vanoxerine is an investigational drug which is being evaluated for the treatment of heart arrhythmias and cocaine dependence. Vanoxerine is a piperazine derivative which has multiple pharmacological activities including acting as an dopamine reuptake inhibitor, serotonin transporter inhibitor, and as a blocker of the cardiac hERG repolarizing potassium channel (IKr).
== Research ==
Excerpted from Wikipedia’s “vanoxerine” article, available under the CC BY-SA 4.0 licence.